A drug initially discovered to treat fungal infections may be the key to treating and managing metabolic disorders.
Rapamycin is a drug discovered from soil bacteria on Easter Island. Named for Easter Island’s original name, Rapa Nui, rapamycin has been extensively studied and approved to be an immunosuppressant drug for organ transplant recipients.
Animal model studies have also shown that this drug might effectively treat Alzheimer’s disease and potentially prolong life for as long as possible. Since it promotes longevity, this drug might also treat metabolic disorders.